-
1
المؤلفون: Sujith Dhanasiri, Austin Kulasekararaj, N.J. Brereton, D. Lee
المصدر: PharmacoEconomics Open
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, business.industry, Health Policy, MEDLINE, Nice, Disease, Clinical trial, Orphan drug, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, medicine, Relevance (law), Pharmacology (medical), Original Research Article, business, Intensive care medicine, computer, Reimbursement, 030215 immunology, Lenalidomide, medicine.drug, computer.programming_language
-
2
المؤلفون: N.J. Brereton, Ron Akehurst, S. Armstrong, D. Hertz, Stacey L. Amorosi, David R. Holmes, Vivek Y. Reddy
المصدر: Europace. 18:979-986
مصطلحات موضوعية: medicine.medical_specialty, Ticlopidine, Time Factors, Pyridones, Cost effectiveness, Cost-Benefit Analysis, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Germany, Physiology (medical), Atrial Fibrillation, medicine, Humans, Atrial Appendage, cardiovascular diseases, 030212 general & internal medicine, Cardiac Surgical Procedures, Stroke, health care economics and organizations, Aspirin, business.industry, Contraindications, Warfarin, Anticoagulants, Atrial fibrillation, Cost-effectiveness analysis, Models, Theoretical, medicine.disease, Clopidogrel, Markov Chains, Surgery, Treatment Outcome, Quality of Life, Pyrazoles, Apixaban, Quality-Adjusted Life Years, Cardiology and Cardiovascular Medicine, business, medicine.drug
-
3
المؤلفون: Michael A. Kamm, Keith Bodger, Songkai Yan, N.J. Brereton, Ron Akehurst, Paul Hodgkins
المصدر: Journal of Medical Economics. 13:148-161
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Severity of Illness Index, Gastroenterology, Time, chemistry.chemical_compound, Mesalazine, Internal medicine, Confidence Intervals, medicine, Health Status Indicators, Humans, Economics, Pharmaceutical, Mesalamine, National health, Models, Statistical, business.industry, Health Policy, Anti-Inflammatory Agents, Non-Steroidal, Uncertainty, Cost-effectiveness analysis, medicine.disease, Ulcerative colitis, Markov Chains, United Kingdom, Models, Economic, chemistry, Quality of Life, Colitis, Ulcerative, Quality-Adjusted Life Years, business, MMX
-
4
المؤلفون: N.J. Brereton, Daniel Gladwell, JK Porter, D. Lee, S. K. Nielsen
المصدر: Journal of medical economics. 17(4)
مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Cost-Benefit Analysis, Population, Gonadotropin-Releasing Hormone, Prostate cancer, chemistry.chemical_compound, Quality of life, Internal medicine, medicine, Humans, Degarelix, education, Gynecology, Cost–utility analysis, education.field_of_study, business.industry, Health Policy, Prostatic Neoplasms, Prostate-Specific Antigen, medicine.disease, Markov Chains, United Kingdom, Quality-adjusted life year, Clinical trial, Models, Economic, chemistry, Clinical Trials, Phase III as Topic, Quality of Life, Quality-Adjusted Life Years, Leuprolide, business, Oligopeptides, Hormone
-
5
المؤلفون: C. Righetti, Becky Pennington, M. Lebmeier, N.J. Brereton
المصدر: Value in Health. 16(7)
مصطلحات موضوعية: medicine.medical_specialty, immune system diseases, business.industry, Cost effectiveness, First line, Rheumatoid arthritis, Health Policy, Public Health, Environmental and Occupational Health, Medicine, business, medicine.disease, Intensive care medicine
-
6
المؤلفون: G.E. Shields, K. Little, N.J. Brereton
المصدر: Value in Health. 15(7)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Health Policy, Immunology, medicine, Public Health, Environmental and Occupational Health, Budgetary impact, medicine.disease, Intensive care medicine, business, Coeliac disease
-
7
المؤلفون: D. Lee, D. Gladwell, A. Batty, E. Tate, N.J. Brereton
المصدر: Value in Health. 15(7)
مصطلحات موضوعية: Cost effectiveness, business.industry, Anesthesia, Health Policy, medicine, Public Health, Environmental and Occupational Health, Midazolam, business, Hybrid model, medicine.drug
-
8
المؤلفون: D. Fisher, N.J. Brereton, S. Kildegaard nielsen, E. Tate
المصدر: Value in Health. 14(7)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cost–utility analysis, business.industry, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Prostate cancer, chemistry.chemical_compound, chemistry, hemic and lymphatic diseases, Internal medicine, medicine, Degarelix, business, neoplasms, Hormone
-
9
المؤلفون: N.J. Brereton, C. Almond, E. Hayward, Nick Freemantle
المصدر: Value in Health. 14(7)
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, Cost effectiveness, Health Policy, Treatment comparison, Public Health, Environmental and Occupational Health, Macular oedema, medicine.disease, Surgery, Ophthalmology, Dexamethasone Intravitreal Implant, Medicine, Branch retinal vein occlusion, business, medicine.drug
-
10
المؤلفون: N.J. Brereton, J. Latimer, A.M. Chapman, C. Almond
المصدر: Value in Health. 14(7)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Remote patient monitoring, Health Policy, Public Health, Environmental and Occupational Health, Budgetary impact, Monitoring system, Primary care, Telehealth, medicine.disease, Heart failure, medicine, Medical emergency, business, Intensive care medicine
-
11
المؤلفون: Becky Pennington, C. Righetti, M. Lebmeier, N.J. Brereton
المصدر: Value in Health. 16(7):A578-A579
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, business.industry, Rheumatoid arthritis, First line, Health Policy, medicine, Public Health, Environmental and Occupational Health, medicine.disease, business, Intensive care medicine
-
12
المؤلفون: S. Shergill, N.J. Brereton, William Wong, A Hirst, C. Almond
المصدر: Value in Health. 16(7):A506-A507
مصطلحات موضوعية: medicine.medical_specialty, business.product_category, Bimatoprost, Open angle glaucoma, Cost effectiveness, business.industry, Dorzolamide/Timolol, Health Policy, Public Health, Environmental and Occupational Health, Timolol, Ophthalmology, Bottle, medicine, Preservative free, business, medicine.drug
-
13
المؤلفون: D. Lee, D. Gladwell, E. Tate, A. Batty, N.J. Brereton
المصدر: Value in Health. 15:A555
مصطلحات موضوعية: Epilepsy, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Medicine, Exploratory analysis, business, medicine.disease, Clinical psychology
-
14
المؤلفون: E. Tate, N.J. Brereton, D. Lee, D. Gladwell, A. Batty
المصدر: Value in Health. 15:A323
مصطلحات موضوعية: Clinical trial, biology, Operations research, Cost effectiveness, business.industry, Health Policy, Puma, Public Health, Environmental and Occupational Health, Authorization, Medicine, Operations management, biology.organism_classification, business
-
15
المؤلفون: K. Tolley, O.A. Mesa, N.J. Brereton, Felix A. Achana, M. Lebmeier, A. Hutchings
المصدر: Value in Health. (7):A478
مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Type 2 Diabetes Mellitus, Saxagliptin, chemistry.chemical_compound, chemistry, Internal medicine, Sitagliptin, medicine, business, medicine.drug
-
16
المؤلفون: D. Lee, N.J. Brereton, E. Tate, D. Gladwell, S. K. Nielsen
المصدر: Value in Health. (7):A421
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Cost effectiveness, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Prostate cancer, chemistry.chemical_compound, chemistry, Internal medicine, Medicine, Degarelix, business
-
17
المؤلفون: C. Almond, N.J. Brereton
المصدر: Value in Health. (7):A490
مصطلحات موضوعية: Actuarial science, Public economics, Health Policy, Public Health, Environmental and Occupational Health, Economics, Health technology, Expected value of perfect information